Clinical trial
Pilot Study for HLA Identical Living Donor Renal Transplant Recipients
NCT00352092 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00352092 |
|---|---|
| Title | Pilot Study for HLA Identical Living Donor Renal Transplant Recipients |
| Official title | A Pilot Study of Corticosteroid-Free, Calcineurin-Sparing Immunosuppression Protocol for HLA-Identical Living Donor Renal Transplant Recipient |
| Lead sponsor | University of Cincinnati, Other |
| Collaborators | Roche Pharma AG Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Renal Transplant |
| Intervention type | Drug |
| Interventions | calcineurin inhibitor, sirolimus, mycophenolate mofetil |
| Enrollment | 20 |
| Start date | Jun 1, 2002 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jul 14, 2006 |
| Last update posted | Nov 13, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: